How Lombardi was paid
$6M in total for fiscal 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|
| Ronald M. LombardiChair, President, and Chief Executive Officer | $1,003,564 | $4,099,959 | $850,000 | $51,024 | $6,004,547 |
| Christine SaccoChief Financial Officer and Chief Operating Officer | $716,242 | $1,608,733 | $364,650 | $24,203 | $2,713,828 |
| Adel MekhailExecutive Vice President, Sales and Marketing | $548,549 | $543,934 | $221,952 | $15,908 | $1,330,343 |
| William C. P’PoolSenior Vice President, General Counsel and Corporate Secretary | $565,565 | $562,024 | $191,080 | $13,923 | $1,332,592 |
| Jeffrey ZerilloSenior Vice President, Operations | $384,227 | $381,044 | $111,404 | $15,908 | $892,583 |
What changed and why
- $6M$6,004,547 CEO total compensation declined from $6,193,019 in fiscal 2025.
- $4.1M$4,099,959 CEO stock awards represented the largest component of fiscal 2026 compensation.
- 3-year performance stock units use cumulative adjusted sales and EBITDA targets.
- $1.6M$1,575,055 one-time retention award was granted to Christine Sacco in fiscal 2025.
- $110K54:1 CEO-to-median-employee pay ratio was based on median compensation of $110,232.
- 97%97% of shares supported the prior year's say-on-pay vote.
Other Prestige Consumer Healthcare proxy statements
- 2025 proxy statement
Ronald M. Lombardi paid $6.2M, pay ratio 75:1.
Filed Jun 27, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.